Insulet Corporation

US$146.51As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PODDHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 14.68%
Div yield —
ROE 28.93%
Medical Devices
Beta (5Y) 1.05
PE TTM 23.90
TSR TTM (53.19%)
Mkt cap US$10.16B
ROIC 23.33%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$155
5.68%
217.18%
Sell 4|4|2|4|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.66
1.69
1.80
1.83
34.21%
22.75%
33.61%
23.33%
Revenue$B
1.187
1.218
1.278
1.318
15.02%
13.73%
18.08%
15.72%
Peers (US$10.16B)
Cap (US$)
PE
9.412B
17.50x
9.363B
—
11.76B
24.51x
Capital
TTM
5Y
10Y
Leveragex
0.572
0.121
0.098
EBIT/Intx
1.274
0.511
0.404
Own earn%
(27.43)
(14.48)
(38.47)
Sh yield%
24.97
20.66
20.51
Owners
Insiders/Inst%
10.41
31.28
Short interest%
4.24
SBC / revenue%
3.31
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
1–4
$1 testx
—
Incr. ROIC%
6